$DULL

BANK OF MONTREAL /CAN/

0
1
0

No SEC Form 4 filings for $DULL in the last 30 days.

Med

Bank Of Montreal (BMO) Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Matthew Lee reaffirmed a Buy rating for Bank Of Montreal, with a reported average return of 21.7% in the Financial sector. Despite a consensus Moderate Buy rating and a price target suggesting a downside, corporate insider sentiment for BMO is positive, indicating increased insider buying. Raymond James also recently maintained a Buy rating for the stock.

ACRNQXX Stock Price and Chart — NASDAQ:ACRNQXX

This page provides an overview of the ACRNQXX stock, identified as a Bank of Montreal Point to Point Barrier Note listed on the Nasdaq Stock Market. It shows the stock's current status as "Market closed" with "No trades" and offers options to view its full chart over various timeframes. The site also suggests related funds and provides market and reference data from ICE Data Services and FactSet.

Bank of Montreal Wins FCA Approval for Third Supplement to $40 Billion Note Programme

Bank of Montreal has received approval from the UK Financial Conduct Authority for the third supplement to its U.S.$40 billion Note Issuance Programme, dated March 2, 2026. This approval enhances regulatory transparency for investors and ensures the bank's continued access to global debt capital markets. The updated framework supports Bank of Montreal's ongoing use of structured note issuance to fund operations and manage its capital structure internationally.